Citigroup »

Verve Therapeutics shares owned by Citigroup

Quarter-by-quarter ownership of Verve Therapeutics (VERV) shares owned by Citigroup from 13F filings

Historical chart of Citigroup investment in Verve Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Verve Therapeutics held by Citigroup consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Verve Therapeutics by Citigroup

Quarter filed Position value Share count Share price at filing
2023-12-31 $2.0M 144k 13.91
2023-09-30 $1.6M 121k 13.33
2023-03-31 $7.1M 494k 14.42
2022-12-31 $3.2M 166k 19.35
2022-09-30 $6.7M 168k 40.00
2021-12-31 $4.5M 121k 36.87